rifamycin B

[(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-acetyloxy-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-9-yloxy]acetic acid

SQTCRTQCPJICLD-KTQDUKAHSA-N CHEBI:17876 0 Reactome links 5 studies
5 Observed studies
5 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
SQTCRTQCPJICLD-KTQDUKAHSA-N
IUPAC name
[(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-acetyloxy-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-9-yloxy]acetic acid
Preferred name
rifamycin B
INN name
Synonym
Rifamycin B
ChEBI
CHEBI:17876

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles